| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
20.92 |
B.V. (₹) |
99.70 |
| Sales(₹ Cr.) |
1,055.07 |
NP (₹ Cr.) |
240.92 |
| NP Var% |
-30.00 |
Div% |
755.00 |
| CPS(₹) |
15.10 |
EPS (₹) |
11.50 |
| Traded Value(₹ Lakhs) |
104.77 |
52 Week High |
807.00 |
| 52 Week Low |
494.00 |
Price BSE |
612.00 |
| Price NSE |
612.00 |
Market Capital (₹ Cr.) |
12,800.84 |
| P/C Ratio |
40.60 |
P/E Ratio |
53.20 |
| Price Vs.BV |
6.14 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
312.31 |
| NP(₹ Cr.) |
75.71 |
NP Var % |
20.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
1,085.75 |
| OPM |
42.50 |
NP |
328.71 |
| NP Var% |
-7.56 |
EPS |
14.20 |
| PE |
43.08 |
|
|